Search research articles
Contact Us
Filters
Showing results (1-10 of 125) with videos related to
Page
of 13
Sort By:
Clinics and Research in Hepatology and Gastroenterology
|
May 29, 2012
Liver transplantation for hepatocellular carcinoma: time for an international consensus
Thomas Decaens
Clinics and Research in Hepatology and Gastroenterology
|
July 12, 2011
Contribution of biomarkers and imaging in the management of hepatocellular carcinoma
Laetitia Fartoux, Thomas Decaens
European Journal of Cancer (Oxford, England : 1990)
|
November 18, 2017
Liver immunotolerance and hepatocellular carcinoma: Patho-physiological mechanisms and therapeutic perspectives
Gaël S Roth, Thomas Decaens
Cancers
|
September 23, 2020
Reply to Comment on "Jilkova, Z.M.; et al. Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges" <i>Cancers</i> 2019, <i>11</i>, 1554
Zuzana Macek Jilkova, Caroline Aspord, Thomas Decaens
Current Opinion in Oncology
|
December 19, 2021
Immunomodulation for hepatocellular carcinoma therapy: current challenges
Zuzana Macek Jilkova, Julien Ghelfi, Thomas Decaens
Cancers
|
October 17, 2019
Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges
Zuzana Macek Jilkova, Caroline Aspord, Thomas Decaens
Cancers
|
October 5, 2019
Animal Models of Hepatocellular Carcinoma: The Role of Immune System and Tumor Microenvironment
Zuzana Macek Jilkova, Keerthi Kurma, Thomas Decaens
Presse Medicale (Paris, France : 1983)
|
August 14, 2009
[Liver transplantation for hepatocellular carcinoma and for patients with pre-existing cancers]
Monika Hurtova, Thomas Decaens, Alexis Laurent, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
December 26, 2022
Immunotherapy in hepatocellular carcinoma: How does underlying liver disease influence therapeutic strategy and outcomes?
Gael S Roth, François Villeret, Thomas Decaens, et al.
Journal of Hepatology
|
December 7, 2013
Targeting the mTOR pathway in hepatocellular carcinoma: current state and future trends
Matthias S Matter, Thomas Decaens, Jesper B Andersen, et al.
Page
of 13
Search research articles
Search
Showing results (1-10 of 125) with videos related to
Sort By:
Page
of 13
Clinics and Research in Hepatology and Gastroenterology
|
May 29, 2012
Liver transplantation for hepatocellular carcinoma: time for an international consensus
Thomas Decaens
Clinics and Research in Hepatology and Gastroenterology
|
July 12, 2011
Contribution of biomarkers and imaging in the management of hepatocellular carcinoma
Laetitia Fartoux, Thomas Decaens
European Journal of Cancer (Oxford, England : 1990)
|
November 18, 2017
Liver immunotolerance and hepatocellular carcinoma: Patho-physiological mechanisms and therapeutic perspectives
Gaël S Roth, Thomas Decaens
Cancers
|
September 23, 2020
Reply to Comment on "Jilkova, Z.M.; et al. Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges" <i>Cancers</i> 2019, <i>11</i>, 1554
Zuzana Macek Jilkova, Caroline Aspord, Thomas Decaens
Current Opinion in Oncology
|
December 19, 2021
Immunomodulation for hepatocellular carcinoma therapy: current challenges
Zuzana Macek Jilkova, Julien Ghelfi, Thomas Decaens
Cancers
|
October 17, 2019
Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges
Zuzana Macek Jilkova, Caroline Aspord, Thomas Decaens
Cancers
|
October 5, 2019
Animal Models of Hepatocellular Carcinoma: The Role of Immune System and Tumor Microenvironment
Zuzana Macek Jilkova, Keerthi Kurma, Thomas Decaens
Presse Medicale (Paris, France : 1983)
|
August 14, 2009
[Liver transplantation for hepatocellular carcinoma and for patients with pre-existing cancers]
Monika Hurtova, Thomas Decaens, Alexis Laurent, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
December 26, 2022
Immunotherapy in hepatocellular carcinoma: How does underlying liver disease influence therapeutic strategy and outcomes?
Gael S Roth, François Villeret, Thomas Decaens, et al.
Journal of Hepatology
|
December 7, 2013
Targeting the mTOR pathway in hepatocellular carcinoma: current state and future trends
Matthias S Matter, Thomas Decaens, Jesper B Andersen, et al.
Page
of 13